S&P 500   3,841.18 (+1.93%)
DOW   31,487.32 (+1.82%)
QQQ   308.45 (+1.43%)
AAPL   121.02 (+0.74%)
MSFT   231.92 (+2.29%)
FB   263.97 (+2.46%)
GOOGL   2,092.49 (+2.88%)
TSLA   595.24 (-4.22%)
AMZN   2,996.55 (+0.64%)
NVDA   497.68 (+0.58%)
BABA   234.71 (+1.83%)
CGC   30.94 (-0.23%)
GE   13.49 (-0.59%)
MU   88.86 (+5.37%)
NIO   37.50 (-4.53%)
AMD   78.43 (+0.87%)
T   29.65 (+2.52%)
F   12.24 (+2.60%)
ACB   9.55 (-2.75%)
DIS   189.80 (+0.94%)
BA   221.49 (-1.43%)
NFLX   512.86 (+0.31%)
BAC   36.94 (+1.21%)
S&P 500   3,841.18 (+1.93%)
DOW   31,487.32 (+1.82%)
QQQ   308.45 (+1.43%)
AAPL   121.02 (+0.74%)
MSFT   231.92 (+2.29%)
FB   263.97 (+2.46%)
GOOGL   2,092.49 (+2.88%)
TSLA   595.24 (-4.22%)
AMZN   2,996.55 (+0.64%)
NVDA   497.68 (+0.58%)
BABA   234.71 (+1.83%)
CGC   30.94 (-0.23%)
GE   13.49 (-0.59%)
MU   88.86 (+5.37%)
NIO   37.50 (-4.53%)
AMD   78.43 (+0.87%)
T   29.65 (+2.52%)
F   12.24 (+2.60%)
ACB   9.55 (-2.75%)
DIS   189.80 (+0.94%)
BA   221.49 (-1.43%)
NFLX   512.86 (+0.31%)
BAC   36.94 (+1.21%)
S&P 500   3,841.18 (+1.93%)
DOW   31,487.32 (+1.82%)
QQQ   308.45 (+1.43%)
AAPL   121.02 (+0.74%)
MSFT   231.92 (+2.29%)
FB   263.97 (+2.46%)
GOOGL   2,092.49 (+2.88%)
TSLA   595.24 (-4.22%)
AMZN   2,996.55 (+0.64%)
NVDA   497.68 (+0.58%)
BABA   234.71 (+1.83%)
CGC   30.94 (-0.23%)
GE   13.49 (-0.59%)
MU   88.86 (+5.37%)
NIO   37.50 (-4.53%)
AMD   78.43 (+0.87%)
T   29.65 (+2.52%)
F   12.24 (+2.60%)
ACB   9.55 (-2.75%)
DIS   189.80 (+0.94%)
BA   221.49 (-1.43%)
NFLX   512.86 (+0.31%)
BAC   36.94 (+1.21%)
S&P 500   3,841.18 (+1.93%)
DOW   31,487.32 (+1.82%)
QQQ   308.45 (+1.43%)
AAPL   121.02 (+0.74%)
MSFT   231.92 (+2.29%)
FB   263.97 (+2.46%)
GOOGL   2,092.49 (+2.88%)
TSLA   595.24 (-4.22%)
AMZN   2,996.55 (+0.64%)
NVDA   497.68 (+0.58%)
BABA   234.71 (+1.83%)
CGC   30.94 (-0.23%)
GE   13.49 (-0.59%)
MU   88.86 (+5.37%)
NIO   37.50 (-4.53%)
AMD   78.43 (+0.87%)
T   29.65 (+2.52%)
F   12.24 (+2.60%)
ACB   9.55 (-2.75%)
DIS   189.80 (+0.94%)
BA   221.49 (-1.43%)
NFLX   512.86 (+0.31%)
BAC   36.94 (+1.21%)
Log in
NASDAQ:ABUS

Arbutus Biopharma SEC Filings & 10K Form

$3.15
+0.01 (+0.32 %)
(As of 03/5/2021 03:20 PM ET)
Add
Compare
Today's Range
$2.91
Now: $3.15
$3.25
50-Day Range
$3.64
MA: $4.07
$4.84
52-Week Range
$0.88
Now: $3.15
$9.02
Volume243,443 shs
Average Volume3.12 million shs
Market Capitalization$267.46 million
P/E RatioN/A
Dividend YieldN/A
Beta3.15

SEC Filings

Arbutus Biopharma (NASDAQ:ABUS) SEC Filings

DateFilerForm TypeView
03/04/2021
4:12 PM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2021
4:05 PM
Arbutus Biopharma (Filer)
Form 424B5
03/04/2021
3:32 PM
Arbutus Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2021
6:32 AM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2021
6:32 AM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/17/2021
4:06 PM
Arbutus Biopharma (Issuer)
HASTINGS DAVID C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
3:57 PM
Arbutus Biopharma (Issuer)
Howard Elizabeth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
3:55 PM
Arbutus Biopharma (Issuer)
McElhaugh Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
3:52 PM
Arbutus Biopharma (Issuer)
Sofia Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
9:46 AM
Arbutus Biopharma (Subject)
Foresite Capital Fund IV, L.P. (Filed by)
Form SC 13G/A
02/12/2021
8:23 AM
Arbutus Biopharma (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/10/2021
4:06 PM
Arbutus Biopharma (Issuer)
McElhaugh Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2021
11:13 AM
Arbutus Biopharma (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G/A
02/01/2021
6:30 AM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2021
6:32 AM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2020
3:33 PM
Arbutus Biopharma (Issuer)
McElhaugh Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2020
6:32 AM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2020
7:00 AM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
3:11 PM
Arbutus Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
7:30 AM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2020
11:15 PM
Arbutus Biopharma (Filer)
Form EFFECT
09/25/2020
3:06 PM
Arbutus Biopharma (Issuer)
Picchio Gaston (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2020
3:05 PM
Arbutus Biopharma (Issuer)
Collier William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2020
6:32 AM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2020
3:39 PM
Arbutus Biopharma (Filer)
Form CT ORDER
08/28/2020
3:06 PM
Arbutus Biopharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/27/2020
7:17 AM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
5:44 AM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2020
4:24 PM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2020
3:54 PM
Arbutus Biopharma (Filer)
Form 424B5
08/07/2020
3:48 PM
Arbutus Biopharma (Filer)
Form 424B5
08/07/2020
6:34 AM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/27/2020
4:27 PM
Arbutus Biopharma (Issuer)
McElhaugh Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2020
8:13 PM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2020
11:56 AM
Arbutus Biopharma (Filer)
Form CT ORDER
07/16/2020
3:22 PM
Arbutus Biopharma (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G
06/24/2020
3:22 PM
Arbutus Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/01/2020
4:04 PM
Arbutus Biopharma (Issuer)
Meyers James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2020
4:03 PM
Arbutus Biopharma (Issuer)
HENRIQUES RICHARD C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2020
4:02 PM
Arbutus Biopharma (Issuer)
Collier William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2020
4:01 PM
Arbutus Biopharma (Issuer)
Torti Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
7:29 AM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2020
7:02 AM
Arbutus Biopharma (Filer)
Form DEF 14A
03/26/2020
4:17 PM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2020
3:06 PM
Arbutus Biopharma (Filer)
Form 10-K/A
03/05/2020
6:33 AM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2020
7:05 AM
Arbutus Biopharma (Issuer)
Howard Elizabeth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
7:05 AM
Arbutus Biopharma (Issuer)
Sofia Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
7:04 AM
Arbutus Biopharma (Issuer)
Picchio Gaston (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
7:04 AM
Arbutus Biopharma (Issuer)
Collier William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
7:03 AM
Arbutus Biopharma (Issuer)
HASTINGS DAVID C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
7:02 AM
Arbutus Biopharma (Issuer)
McElhaugh Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
7:01 AM
Arbutus Biopharma (Issuer)
Venker Eric (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/19/2020
7:00 AM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
12:50 PM
Arbutus Biopharma (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G/A
02/14/2020
12:44 PM
Arbutus Biopharma (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/10/2020
7:05 AM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
7:45 AM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2019
3:09 PM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2019
7:24 PM
Arbutus Biopharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/09/2019
1:15 PM
Arbutus Biopharma (Subject)
Foresite Capital Fund IV, L.P. (Filed by)
Form SC 13G
11/06/2019
11:27 AM
Arbutus Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
6:34 AM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
1:42 PM
Arbutus Biopharma (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SC 13G
10/03/2019
3:16 PM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2019
3:14 PM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2019
3:18 PM
Arbutus Biopharma (Issuer)
Cheng Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
3:17 PM
Arbutus Biopharma (Issuer)
POTTER MYRTLE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
3:17 PM
Arbutus Biopharma (Issuer)
Cheng Andrew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/20/2019
3:17 PM
Arbutus Biopharma (Issuer)
BURGESS DANIEL D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
3:16 PM
Arbutus Biopharma (Issuer)
Meyers James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
3:16 PM
Arbutus Biopharma (Issuer)
MANCHESTER KEITH S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
3:15 PM
Arbutus Biopharma (Issuer)
HENRIQUES RICHARD C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
3:15 PM
Arbutus Biopharma (Issuer)
Torti Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
3:09 PM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
3:31 PM
Arbutus Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/09/2019
3:05 PM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2019
11:29 AM
Arbutus Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2019
10:32 AM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2019
3:05 PM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2019
4:30 PM
Arbutus Biopharma (Subject)
Roivant Sciences Ltd. (Filed by)
Form SC 13D/A
07/15/2019
8:35 PM
Arbutus Biopharma (Issuer)
Lo Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2019
8:33 PM
Arbutus Biopharma (Issuer)
Machado Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
7:40 PM
Arbutus Biopharma (Issuer)
HALVORSEN OLE ANDREAS (Reporting)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VGE III Portfolio Ltd. (Reporting)
Viking Global Equities II LP (Reporting)
Viking Global Equities LP (Reporting)
Viking Global Equities Master Ltd. (Reporting)
VIKING GLOBAL PERFORMANCE LLC (Reporting)
Viking Long Fund GP LLC (Reporting)
Viking Long Fund Master Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
7:38 PM
Arbutus Biopharma (Issuer)
HALVORSEN OLE ANDREAS (Reporting)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VIKING GLOBAL INVESTORS LP (Reporting)
Viking Global Opportunities GP LLC (Reporting)
Viking Global Opportunities Illiquid Investments Sub-Master LP (Reporting)
Viking Global Opportunities Portfolio GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
6:46 PM
Arbutus Biopharma (Issuer)
SoftBank Vision Fund L.P. (Reporting)
SVF Investments Ltd (0001716729) (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
3:57 PM
Arbutus Biopharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13D/A
07/12/2019
3:51 PM
Arbutus Biopharma (Issuer)
Dexcel Pharma Technologies Ltd. (Reporting)
Dexxon Holdings Ltd. (Reporting)
Oren Dan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
3:47 PM
Arbutus Biopharma (Subject)
QVT Financial LP (Filed by)
Form SC 13D/A
07/12/2019
3:45 PM
Arbutus Biopharma (Subject)
Dexxon Holdings Ltd. (Filed by)
Form SC 13D/A
07/12/2019
3:39 PM
Arbutus Biopharma (Issuer)
QVT Associates GP LLC (Reporting)
QVT Fund V LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
3:34 PM
Arbutus Biopharma (Subject)
SVF Investments Ltd (0001716729) (Filed by)
Form SC 13D/A
07/03/2019
3:28 PM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2019
3:18 PM
Arbutus Biopharma (Issuer)
Collier William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:18 PM
Arbutus Biopharma (Issuer)
Collier William H. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2019
3:00 PM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2019
3:53 PM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2019
5:07 AM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
4:30 PM
Arbutus Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2019
4:02 PM
Arbutus Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.